Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The general objective of the study is to estimate the systemic pharmacokinetics of mannitol
after single and multiple dosing of IDPM 400 mg to adult and paediatric cystic fibrosis
patients.